Secondary analysis of ORBITA (131 patients with stable angina): with low microvascular resistance, PCI increased exercise time by 48 s vs placebo procedure; with high resistance, 16 s (no clear gain). Evidence for an interaction was modest.
Secondary analysisn = 131
Taylor et al. Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention: Microvascular-Stratified Analysis of ORBITA